Taq1A polymorphism and medication effects on inhibitory action control in Parkinson disease

BACKGROUND: Dopamine therapy in Parkinson disease (PD) can have differential effects on inhibitory action control, or the ability to inhibit reflexive or impulsive actions. Dopamine agonist (DAAg) medications, which preferentially target D2 and D3 receptors, can either improve or worsen control of i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Brain Behav
Asıl Yazarlar: McDonell, Katherine E., van Wouwe, Nelleke C., Harrison, Madaline B., Wylie, Scott A., Claassen, Daniel O.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2018
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6043698/
https://ncbi.nlm.nih.gov/pubmed/29856137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1008
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller